MENU

Public Relations

Coverage

FY2020

You can scroll horizontally.

No. Date Media Broadcasting channel
Newspaper, journal
Headline, title Page
  3/25/2021 Newspaper The Science News Utilization of CRISPR / Cas9 and nanomicelles  
  3/24/2021 Newspaper Tokyo Shimbun  the 1st iCONM Public Lecture  
  3/23/2021 Newspaper The Chemical Daily Drug for regeneration of cartilage, starts clinical trial in 2023  
  3/20/2021 TV ABC "Oshiete News Live~Seiginomikata"  
  3/20/2021 Newspaper
Web
newswitch "Genome editing" for Alzheimer's disease treatment,  Will it  be put to practical use?  
  3/19/2021 Newspaper The Science News COINS Seminar # 57 held   
  3/19/2021 Magazine
Web
TOWNNEWS COINS "In-Body Hospitals"  received the Selection Committee Special Award.  Industry-Academia-Government collaboration was recognized.  
  3/19/2021 Magazine
Web
TOWNNEWS Research Leader of "In-Body Hospitals"  Dr, Kazunori Kataoka     Director General, Innovation Center of NanoMedicine     70 years old  
  3/19/2021 Newspaper THE NIKKAN KOGYO SHIMBUN,LTD. CRISPR Cas9, Treat refractory brain disease iCONM・Kyoto Prefectural University of Medicine  
  3/18/2021 Radio Kawasaki FM Kawasaki Hot☆Studio  
  3/15/2021 web Bio Techniques Bringing CRISPR closer to therapeutic use for brain disorders  
  3/15/2021 Radio Kawasaki FM Kawasaki Hot☆Studio  
  3/14/2021 TV BS Asahi Special program for the 20th Anniversary of starting broadcasting   Latest medical care for the life of 120 years - Towards an era where cancer
and diabetes are cured. 
 
  3/12/2021 web Nikkei Biotechology & Business Innovation Center of NanoMedicine (iCONM) succeeds in intracerebral genome editing by co-encapsulation of CRISPR/Cas9 and nanomicelles
-  enables efficient genome editing in mouse brain 
 
  3/12/2021 Web
Newspaper insert flyer
TOWNNEWS A course to learn "Future medical care" by iCONM on the web.  
  3/11/2020 Web Iyakutsushinsha Develop CRISPR / Cas9 delivery method   Expect for therapeutic application such as Alzheimer's disease. iCONM.  
  3/10/2021 TV tvk Nekonohitaihodowaido  
  3/10/2021 Web research-er.jp Succeed to develop the efficacy of polymeric nano-micelles with different drug activation profiles depends on the expression level of c-Myc.  
  3/9/2021 Web QLifePro It’s likely that therapeutic agents targeting the long non-coding RNA "TUG1" may be effective for pancreatic cancer.- Nagoya University and others.  
  3/5/2021 Web TOWNNEWS Kawasaki-ku Tonomachi Innovation Center of NanoMedicine  illustrates future medical care
"Nano medical care"  Move to children's disinterest in science
 
  3/5/2021 Web Nikkei Business Publications, Inc. Target cancer gene  Nanomachines make up for weaknesses of medicine  
  3/4/2021 Web crisp_bio Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables efficient genome editing in mouse brain  
  3/2/2021 Web Statnano Nanomedicine Activation Profile Determines Efficacy Depending on Tumor c-Myc Expression  
  3/2/2021 Newspaper The Chemical Daily Nagoya University et al.  create nucleic acid drugs for pancreatic cancer   Increased efficacy of chemotherapeutic agent P6
  3/2/2021 Web Nikkei Biotechology & Business Nagoya University synthesizes nucleic acid medicine micelle which overcomes 5-FU resistance of pancreatic cancer  
  3/1/2021 Web Azo nano Efficacy of Polymeric Nano-Micelles Depends on c-Myc Expression Level  
  3/1/2021 Web Phys.org Nanomedicine activation profile determines efficacy depending on tumor c-Myc expression  
  3/1/2021 Web Iyakutsushinsha Introduce research contents and facilities with iCONM Kids video  
  3/1/2021 Newspaper The Hokkaido Shimbun Early realization of vaccine   Based on past research P2
  2/28/2021 Web dutifulnews Nanomedicine activation profile determines efficacy depending on tumor c-Myc expression  
  2/27/2021 Web verietyinfo The efficiency of polymeric nano-micelles depends on the expression level of c-Myc  
  2/27/2021 TV NHK World-Japan mRNA: Medical Messenger of Hope  
  2/27/2021 Web News Medical life Sciences Efficacy of polymeric nano-micelles depends on expression level of c-Myc  
  2/26/2021 Web Nikkei Biotechology & Business iCONM realizes to use drugs properly according to gene expression with functional nanocapsules.  
  2/26/2021 Web Phys.org Nanomedicine activation profile determines efficacy depending on tumor c-Myc expression  
  2/26/2021 Web 4State.News Nanomedicine activation profile determines efficacy depending on tumor c-Myc expression  
  2/25/2021 Web EurekAlert Nanomedicine activation profile determines efficacy depending on tumor c-Myc expression  
  2/22/2021 Web Iyakutsushinsha Expect venture companies from iCONM /COINS provide a spark for the development of King SkyFront.
COINS Seminar 56
 
  2/20/2021 Web Iyakutsushinsha Develop JQ1 micell  that can choose release patterns according to c-Myc expression level.  
  2/19/2021 Web Iyakutsushinsha Receive "Japan Open Innovation Prize (JOIP) Selection Committee Special Award" COINS  
  2/19/2021 Web TOWNNEWS Release  a new PR video of  Tonomachi International Strategic Zone King SkyFront
Treatment of intractable disease, new drug discovery and vaccine development
 
  2/15/2021 Web Iyaku Keizaionline Develop polymer that carries RNA to cancer  
  2/13/2021 Newspaper The Sanyo Shimbun Speedy development       Tingle with anticipation P4
  2/13/2021 Newspaper KAHOKU SHIMPO Pfizer vaccine   Anxiety about domestic supply cannot be wiped out  
  2/13/2021 Newspaper YOMIURI SHIMBUN Genetic material "mRNA" responds to mutant type P2
  2/13/2021 Web YOMIURI SHIMBUN Online What's behind  Pfizer vaccine "Speed Approval".......Trump card for corona solution,  Cells become "In-Body factory"  
  2/13/2021 Newspaper The Hokkaido Shimbun Speedy development Expectation and anxiety    The government rushes vaccination    Securing the supply is the challenge
Pain and lassitude occurs rather frequently
 
  2/13/2021 Newspaper Saga Shimbun Pfizer vaccine   Build anticipation, Anxiety for securing the supply  
  2/12/2021 Newspaper The Science News Nanomedicine that carries nucleic acid drug    The world’s smallest   iCONM and UTokyo develop  Expectations for treatment of intractable cancer  
  2/8/2021 Newspaper Asahi Shimbun Why the vaccine could be developed in the short term   
  2/2/2021 Web The Mainichi Living informaion under the Novel Coronavirus / Practical use of vaccine in a short period
Accumulated research Fast examination as well
 
  2/1/2021 Newspaper YOMIURI SHIMBUN Prevent nerve cell death with  drugs. P3
  1/29/2021 Web THE MID-JAPAN ECONOMIST Why was corona vaccine made so fast? / Accumulated research /Quick examination as well  
  1/29/2021 Newspaper Nikkei Inc. Relief of memory loss after brain infarction P38
  1/28/2021 Web NHK Administrate "mRNA" to rats with brain infarction. Succeeded in preventing death of cranial nerves  
  1/23/2021 Newspaper The Akita Sakigake. Accumulated research, Quick examination  P26
  1/23/2021 Web The Kitanippon Shimbun why was corona vaccine made so fast?  Accumulated research /quick examination as well  
  1/22/2021 Web Yakuji Nippo Develop ultra-micro nanomedicine - possible to load nucleic acid drugs
Kawasaki Institute of Industrial Promotion
P3
  1/20/2021 Web Miyazaki Nichinichi Shimbun Why was corona vaccie made so fast?  
  1/20/2021 Web headlinesmania.com Researchers are developing small-scale nanomedicines to target non-invasive cancers  
  1/19/2021 Web news-medical.net Researchers develop ultra-small nanomedicines to target intractable cancers  
  1/8/2021 Newspaper The Chemical Daily Exosome analysis end-to-end p5
  1/5/2021 Newspaper The Chemical Daily AMED  CiCLE (Cyclic Innovation for Clinical Empowerment)
adopts 14 projects including mRNA drug development
P6
  12/26/2020 TV TBS "Marutto!Saturday"  
  12/20/2020 TV tv asahi "Sunday Live!!"  
  12/19/2020 TV ABC "Oshiete News Live~Seiginomikata"  
  12/19/2020 Web PRESIDENT Online Why it was possible to produce a vaccine for the new coronavirus in large quantities in a short period of time.  
  12/16/2020 Web Iyakutsushinsha MD,PhD. Matsumura of National Cancer Center gave a lecture on the theme of "Looking back on my DDS research" COINS seminar  
  12/10/2020 Web Forbes JAPAN ranked second in the 2021 edition of "Japan's MIDAS LIST"  
  12/5/2020 Newspaper Kanagawa Shimbun Ltd. Introducing advanced medical research in Tonomachi / Kawasaki  
  12/4/2020 Newspaper The Chemical Daily Release of anti-cancer drug according to pH  
  12/3/2020 Web mixi News Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/3/2020 Web msn News Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/3/2020 Web YAHOO! JAPAN news Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/3/2020 Web JIJI.COM Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Web Rakuten Infoseek News Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Web au WEB Portal domestic News Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Web JIJI Medical Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Web livedoor NEWS Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Web BIGLOBE News Utilizing genetic information, first practical application Shortening development period-mRNA vaccine  
  12/2/2020 Newspaper The Chemical Daily mRNA corona vaccine Expected to have a strong immune response  
  11/30/2020 Web Nikkei Business Publications, Inc. Aim at cancer cells of malignant brain tumors with "super molecular nanomachines"  
  11/30/2020 TV BS11 "Press Live Inside Out "  
  11/29/2020 TV FUJI TELEVISION NETWORK,INC "THE PRIME"   
  11/28/2020 TV ABC "Oshiete News Live~Seiginomikata"  
  11/27/2020 Newspaper Nikkei Inc. Skillfully utilize genetic information for the first practical application of mRNA vaccine P35
  11/26/2020 Web Nikkei Inc. MRNA vaccine, skillfully utilize genetic information quick development  
  11/25/2020 Magazine Forbes JAPAN ranked second in the 2021 edition of "Japan's MIDAS LIST"  
  11/25/2020 Newspaper Nikkei Sangyo Shimbun Release drug inside a brain tumor P7
  11/24/2020 TV TBS "asa chan!"  
  11/22/2020 TV tv asahi "Sunday Live!!"  
  11/21/2020 TV TBS "Marutto!Saturday"  
  11/20/2020 Web YAHOO! JAPAN news "Effectiveness 95%" Western mRNA vaccine which was aghast the world Why vaccine development in Japan is one lap behind  
  11/20/2020 TV FUJI TELEVISION NETWORK,INC "Tokudane!"  
  11/20/2020 Newspaper Shizuoka Shimbun Kawasaki model in Shimizu too  Mr. Yuji Dodo gives lecture at Shimizu Seikei juku Intellectual property Introduce to small and medium-sized companies P19
  11/20/2020 Web livedoor NEWS 【Wide show Tsushinbo】Speedy development of "effect 95%"corona vaccine. Is it alright to start using in December in USA? Japanese expert "I don't know what will happen in the future" (Tokudane!)  
  11/20/2020 Web excite.News 【Wide show Tsushinbo】Speedy development of "effect 95%"corona vaccine. Is it alright to start using in December in USA? Japanese expert "I don't know what will happen in the future" (Tokudane!)  
  11/20/2020 Web JCC If the US vaccine is distributed ... "End schedule"  
  11/19/2020 Newspaper
Web
THE NIKKAN KOGYO SHIMBUN,LTD. Malignant brain tumor treament P26
  11/18/2020 TV tv asahi Hatori Shinichi Morning Show  
  11/18/2020 Web JCAST TV Watch  Pfizer and Moderna's corona vaccine, a new type of excellent vaccine that actually extracts "RNA" from genes! Expected to be applied for  cancer treatment ...  
  11/18/2020 Web Rakuten Infoseek News Pfizer and Moderna's corona vaccine, a new type of excellent vaccine that actually extracts "RNA" from genes! Expected to be applied for  cancer treatment ...  
  11/18/2020 Web JCC New technology "mRNA" also for cancer treatment, Alzheimer's disease  
  11/18/2020 Web JCC Efficacy 94.5% ・ new vaccine ・ almost no side reactions  
  11/9/2020 Newspaper The Chemical Daily Growing importance of " Informed decision" P5
  11/6/2020 Newspaper Kanagawa Shimbun Ltd. Introduce "Future Medicine"  
  11/4/2020 Newspaper The Chemical Daily Corona Vaccine with Partial Double-stranded mRNA P5
  10/12/2020 Web Nikkei Inc. Discriminate the corona aggravation by protein in blood. Professors of Tokyo Medical University and colleagues  
  10/12/2020 Web The Okinawa Times Predict the corona aggravation by blood  Identify candidate substances. Tokyo Medical University  
  10/12/2020 Web KYODO NEWS Predict the corona aggravation by blood  Identify candidate substances. Tokyo Medical University  
  10/12/2020 Web The Chunichi Shimbun Predict the corona aggravation by blood  Identify candidate substances. Tokyo Medical University  
  10/12/2020 Web KAHOKU SHIMPO PUBLISHING Predict the corona aggravation by blood  Identify candidate substances. Tokyo Medical University  
  10/12/2020 Web Nishinippon Shimbun Predict the corona aggravation  
  10/12/2020 Web Niigata Nippou jigyousya Predict the corona aggravation  
  10/12/2020 Web Kanagawa Shimbun Ltd. Predict the corona aggravation  
  9/30/2020 Web Qlife Nucleic acid drug "SRN-14/GL2-800", A doctor-initiated Phase I clinical trial  for unresectable / metastatic recurrent breast cancer starts  
  9/28/2020 Web Iyakutsushinsha Exhibits at「Innovation Japan 2020 - Online University trade show」iCONM  
  9/27/2020 TV BS FUJI If we could go to a micro world?  
  9/18/2020 Newspaper The Science News Start  an investigator-initiated Phase I clinical trials (FIRST IN HUMAN) of nucleic acid drug candidate targeting PRDM14 against breast cancer patients  
  9/15/2020 Web Asahi Shimbun DIGITAL Newsletter "KAWASAKI Coastal Area News" Vol.25 published  
  9/15/2020 Web Iyaku Keizaisha Anti-PD-1 Antibody finds a buddy  
  9/11/2020 Newspaper The Chemical Daily Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. P10
  9/8/2020 Newspaper
Web
THE NIKKAN KOGYO SHIMBUN,LTD. Utilization of “micelle” technology: Possibility for minimally invasive drugs  
  9/7/2020 Web CareNet Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/4/2020 Web Nikkei Biotechnology & Business Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/3/2020 Web QLifePro Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Oncology Tribune Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Iyakutsushinsha Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/2/2020 Web Nikkei medical Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/2/2020 Web The Cancer Institute Hospital Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Neuro-Central A peek behind the paper – Sabina Quader and Rosalía Rodríguez-Rodríguez on nanomedicines for neuron targeting  
  8/21/2020 Newspaper The Science News Effective in combination with immune checkpoint inhibitor and nano-DDS P.4
  8/19/2020 Magazine
Web
Advanced Healthcare Materials mRNA Delivery: Polymeric Nanocarriers with Controlled Chain Flexibility Boost mRNA Delivery In Vivo through Enhanced Structural Fastening  
  8/19/2020 Web Nikkei beyond Health The effect of cancer immunotherapy provides a dramatic improvement with Nanomachines   
  8/14/2020 Newspaper
Web
MYTTLINE 【Countermeasure for coronavirus】Catch a right information in a newspaper! Get to know coronavirus ⑥Gene vaccine, expectations and anxiety  
  8/14/2020 Web Katei Gahou A drug with few side effects. Everyone's dream is consistently and gradually realized.  
  8/12/2020 Newspaper Koureisya jutaku Shimbun Progress in brain drug therapy. Effective for Alzheimer's disease.  
  8/11/2020 Web ONCOLOGY NEWS Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/11/2020 Web Medical Tribune Realization of chemo-immunotherapy using nano-DDS to dramatically enhances the efficacy of immune checkpoint inhibitors against glioblastoma  
  8/9/2020 Web DagoldInfo Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web PHYS ORG Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web 15 MINUTE NEWS Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web SunriseTechno Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Bright Surf.com Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web nano werk Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Bioengineer.org Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Oncolo Glioblastoma, Pinpoint attack, Utilization of nanocapsules  
  8/7/2020 Web Oncology Tribune Improve effect of chemoimmunotherapy on glioblastoma by Nano micelle dramatically.  
  8/7/2020 Newspaper The Chemical Daily New treatment for malignant brain tumor iCONM Cancer immunity + chemotherapy P.8
  8/6/2020 Web EurekAlert Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/6/2020 Web Nikkei Biotechnology & Business iCONM, DDS for glioblastoma enhances the therapeutic effect of ICI P.34
  8/6/2020 Newspaper
Web
Nihon Keizai Shimbun  Glioblastoma, Pinpoint attack, Utilization of nanocapsules P.34
  7/28/2020 Web Burada Biliyorum #Developing a new strategy to selectively deliver therapies to the brain  
  7/28/2020 Web nano THE MAGAZINE FOR SMALL SCIENCE Developing a new strategy to selectively deliver therapies to the brain  
  7/27/2020 Newspaper
Web
Yakuji Nippo Functional advancement of gene therapy drugs-Development of intrahepatic coating agent  Innovation Center of NanoMedicine Group P.3
  7/27/2020 Web  PHARM TECH JAPAN ONLINE Innovation Center of NanoMedicine developed the new method which selectively deliver drugs only to brain tissues.  
  7/27/2020 Web  Iyakutsushinsha Develops a new method which selectively delivers drugs only to brain tissues.
Expect a creation of centrally acting drug iCONM
 
  7/26/2020 Web HYS ORG Developing a new strategy to selectively deliver therapies to the brain  
  7/26/2020 Web EurekAlert! Developing a new strategy to selectively deliver therapies to the brain  
  7/23/2020 TV TV Tokyo Stairs of Quest #42
"Aiming for a panacea with nano medicine" 
 
  7/20/2020 Newspaper The Chunichi Shimbun  "Deeper understanding of Corona!" Development and design at high speed P.20
  7/19/2020 Newspaper Tokyo Shimbun   "Deeper understanding of Corona!" Development and design at high speed P.12
  7/17/2020 TV Ruptly TV Japan: Researchers develop medical Smart Nanomachine that could cure next pandemic  
  7/10/2020 Web Ministry of education About the compilation of "Case Study of Unique Lab Design"  3/4
  7/8/2020 Newspaper The Chemical Daily Improve installation efficiency of gene drugs  Innovation Center of  NaoMedicine, etc. protect liver with PEG
Installation efficiency
P.12
  7/7/2020 Newspaper Nikkei Sangyo Shimbun Dementia treatment with nanomachines Efficient drug delivery to brain cells

P.12
  7/1/2020 Web School of Engineering, The University of Tokyo Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  7/1/2020 Newspaper
Web
Nikkankogyo Shimubun Early establishment of new corona/vaccine development technology
iCONM and TMIMS conduct collaborative research
P.25
  6/30/2020 Newspaper
Web
Nikkankogyo Shimubun Colorectal cancer, gene transfer efficiency 10 times, iCONM and others administrate film agents / capsules. P.26
  6/29/2020 Web National Institutes for Quantum and Radiological Science and Technology Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  6/29/2020 Web Nihon no kenkyū.com Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  6/29/2020 Web Oncology Tribune Development of a safe liver sinusoidal wall coating agent to significantly
increase the efficacy of gene therapy drugs
 
  6/27/2020 Web BIGLOBE news Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/27/2020 Web YAHOO! JAPAN news Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/27/2020 Web Jiji Tsushin Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/26/2020 Newspaper Science newspaper Fully synthetic artificial pancreas device, Tokyo Medical and Dental University, Nagoya University, etc. developed  
  6/26/2020 Web SSIENMAG Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web Nanotechnology News Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web 7thSpace Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web EurekAlert! Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/18/2020 Web Nikkei Beyond Health Closely watch mRNA drugs for the development of a novel coronavirus vaccine  
  6/17/2020 Newspaper
Web
Yakuji Nippo Compound development for control of hepatitis -replace cell growth factor The University of Tokyo/Kawasaki institute of Industrial Promotion Innovation Center of NanoMedicine research group  
  6/12/2020 Newspaper Science newspaper Develop vaccine production technology in preparation for return/reheat of Covid-19
iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research
 
  6/9/2020 Newspaper
Web
Nikkankogyo Shimubun Alzheimer's dementia, suppressed by low dose antibody drug iCONM and others succeeded P.23
  6/9/2020 Newspaper
Web
The Chemical Daily mRNA vaccine, iCONM and TMiMS,  develop for corona  
  6/8/2020 Newspaper
Web
Yakuji Nippo mRNA vaccine production technology, start collaborative research,
Kawasaki institute of Industrial Promotion  Innovation Center of NanoMedicine, Tokyo Metropolitan Institute of Medical Science
P.7
  6/6/2020 Web excite news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/6/2020 Web goo news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/6/2020 Web Mynavi news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/5/2020 Web Yahoo! JAPAN News Development of RNA vaccination technology for new coronavirus
by Kawasaki City Foundation etc.
 
  6/5/2020 Web Iyakutsushinsha iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research of creating technology for the development
of mRNA vaccine integrated with an adjuvant function. 

 
  6/5/2020 Web Jiji Tsushin Development of RNA vaccination technology for new coronavirus
by Kawasaki City Foundation etc.
 
  6/5/2020 Web Nikkei Biotechnology & Business iCONM and Tokyo Metropolitan Institute of Medical Science to develop
mRNA-based vaccine for new corona
 
  6/4/2020 TV TV KANAGAWA Collaborative research on inexpensive vaccine production New Corona  
  6/2/2020 Web Nikkei Beyond Health Insurance covers "Medical device x drug 'fifth cancer treatment'"  
  5/29/2020 Web Iyakutsushinsha Current status and prospects of nanomedicine and chemical surgery development by Dr. Nobuhiro Nishiyama (Professor, Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology)   
  5/27/2020 Web Nikkei Beyond Health Development of Nanomachines to deliver anti-dementia drugs to the brain
 
  5/22/2020 Newspaper The Chemical Daily Delivering therapeutic antibodies into the brain /
Control dementia with a low dose
 
  5/7/2020 Newspaper
Web
Asahi Shimbun
Asahi Shimbun DIGITAL
Discover new type coronavirus antibody Expected to apply to diagnostic agents and test agents  
  5/1/2020 Web BUSINESS INSIDER Aiming to supply "early mass-produced" domestically produced new coronavirus vaccine within the year. Asked the developer about the latest situation.  
  4/30/2020 Web NewsPicks Development of the Functional Polymers that Recognize Biosignals and the Application for Drug Delivery System  
  4/28/2020 Web Deutsche Well COVID-19: Nanomachines to be deployed to fight next viral pandemic  
  4/8/2020 Newspaper
Web
The Chemical Daily mRNA drug: Promising for novel corona virus / Ask Prof. Keiji Itaka, Tokyo Medical and dental University.   
  4/1/2020 Magazine Pharm Tech Japan  Challenge of Industry-government-academia for nucleic acid drug creation (6)
Development of new polymer-based DDS for practical use:
The effort centering on venture companies based on industry-academia collaboration
P.31-37
  4/1/2020 Web RikeLab Succeeded in making DNA into a single-stranded and encapsulate in nanomachines!
World's first technology opens up new possibilities for gene therapy. Science career pictorial book vol.18
Innovation Center of NanoMedicine Dr. Theofilus A. Tockary